Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Regulatoriskt pressmeddelande

Stille AB: Interim Report Q2 2025

Stille
Ladda ner börsmeddelandet

Stille AB (publ) today presents the report for the second quarter 2025.

Revenue amounted to 124.7 MSEK (142.6). Order intake remained strong but was impacted by continued supply-chain constraints, the phase-out of non-strategic products, and currency headwinds.

“Order intake remained strong and largely in line with our growth targets, providing a solid foundation for recovery,” says Ulrik Berthelsen. “We expect our ongoing efforts to strengthen supply chains and reduce lead times will support growth and recovery in the second half of 2025.”

The gross profit margin amounted to 52.1 percent (49.3) and EBIT before one-time costs amounted to 16.6 MSEK (29.1).

MSEKAPR-JUN
2025
APR-JUN
2024
JAN-JUN
2025
JAN-JUN
2024
JUL-JUN
2024/25
JAN-DEC
2024
Net sales124.7 142.6254.0282.3541.7569.9 
Gross profit, %52.149.351.648.953.251.9 
EBITDA before non-recurring items24.436.049.669.6122.4142.4 
EBITDA before non-recurring items, %19.625.219.524.722.625.0 
EBITDA24.432.649.649.698.098.0 
EBITDA, %19.622.919.517.619.117.2 
EBIT before non-recurring items16.629.134.556.193.3114.9 
EBIT before non-recurring items, %13.320.413.619.913.920.2 
EBIT16.625.734.536.068.970.5
EBIT, %13.318.013.612.813.212.4 

Torshälla, July 17th, 2025.

This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-07-17 08:00 CEST.

Contact Details
Ulrik Berthelsen
CEO & President
+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se

About Us
Stille AB (publ) is a well-established pioneer in the development, manufacturing and distribution of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high-precision procedures. Stille was founded in 1841 and is listed on Nasdaq First North Growth Market under the ticker “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, +46 8 684 211 10, adviser@eminova.se. More information is available at www.stille.se.

Attachments
Interim Report Q2 2025

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.